@article{article, title  = {{COST-EFFECTIVENESS (CE) ANALYSIS OF ERBB2-TARGETED THERAPIES IN WOMEN WITH TRASTUZUMAB (TZ)-REFRACTORY ERBB2+METASTATIC BREAST CANCER (MBC) AND LIMITED EXPOSURE TO PRIOR CHEMOTHERAPY (CT)}},

 url = {{}},

 year = {{2009}},

 month = {{5}},

 author = {{Delea T and Sofrygin O and Tappenden P and Browning D and Amonkar MM and Karnon J and Lykopoulos K}},

 volume = {{12}},

 journal = {{VALUE HEALTH}},

 issue = {{3}},

 pages = {{A49-A49}},

 note = {{Accessed on 2024/12/21}}}